The effect of Vitamin D supplementation over mild to moderate asthma outcome in 6-14 years old childre

Phase 2

• Conditions: Condition 1: Asthma. Condition 2: Asthma. Condition 3: Asthma.; Nonallergic asthma; Mixed asthma; Predominantly allergic asthma

• Registration Number: IRCT201110127784N1
• Lead Sponsor: Immunology, Asthma and Allergy Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

inclusion criteria:1- Patients with mild to moderate asthma diagnosed by physician2 - Patients who are less than 3 months of treatment over the past 3 - patients between 6-14 years old; Exclusion criteria: 1 - Patients with severe asthma 2 - patients treated with immunotherapy or anti IgE 3 - Patients with chronic diseases like cardiovascular disease

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FEV1. Timepoint: before and 4-6 months after intervention. Method of measurement: spirometry.;FEV1/FVC. Timepoint: before and 4-6 months after intervention. Method of measurement: spirometry.;Quality of life. Timepoint: before and 4-6 months after intervention. Method of measurement: Questionnaire.;Asthma control. Timepoint: before and 4-6 months after intervention. Method of measurement: Questionnaire.

Secondary Outcome Measures

Name	Time	Method
S-IgE. Timepoint: before and 4-6 months after intervention. Method of measurement: RIDA.